Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19

GÖRMEZ S., Gumusel H. K., Ekicibasi E., DEĞİRMENCİOĞLU A., PAUDEL A., Akan G., ...More

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, vol.122, no.8, pp.582-589, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 122 Issue: 8
  • Publication Date: 2021
  • Doi Number: 10.4149/bll_2021_093
  • Journal Name: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Page Numbers: pp.582-589
  • Keywords: COVID-19, SARS-CoV-2, thrombosis, antithrombotic therapy, low-molecular-weight heparin, D-dimer, enoxaparin, PROPENSITY SCORE, COAGULOPATHY
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

OBJECTIVES: Low molecular weight heparin (LMWH) may provide beneficial effects on outcomes of COVID-19. We aimed to examine the impact of LMWH treatment on clinical outcomes (duration of hospitalization, admission to intensive care unit, the requirement for mechanical ventilation, and death) of COVID-19 patients with normal D-dimer levels at admission.